Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › CHULA VISTA › MARILYN S. NORTON M.D., INC.

MARILYN S. NORTON M.D., INC.

NPI: 1326124819 · CHULA VISTA, CA 91911 · Hematology & Oncology Physician · NPI assigned 10/27/2006

$10.31M
Total Medicaid Paid
128,187
Total Claims
100,765
Beneficiaries
37
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialNORTON, MARILYN (MD./PRESIDENT)
NPI Enumeration Date10/27/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 14,354 $1.34M
2019 18,746 $1.69M
2020 18,117 $1.45M
2021 21,405 $1.82M
2022 22,728 $1.92M
2023 22,130 $1.40M
2024 10,707 $696K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J1439 Injection, ferric carboxymaltose, 1 mg 2,989 1,949 $2.45M
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 2,143 1,698 $1.42M
J0897 Injection, denosumab, 1 mg 802 775 $1.33M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 23,933 22,149 $1.03M
J2505 Injection, pegfilgrastim, 6 mg 186 135 $788K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 7,639 4,886 $502K
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg 115 71 $458K
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg 82 59 $265K
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg 178 81 $245K
J1453 Injection, fosaprepitant, 1 mg 1,357 959 $237K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 39,178 31,149 $185K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 9,402 7,594 $168K
99233 Prolong inpt eval add15 m 4,613 1,190 $156K
99205 Prolong outpt/office vis 1,876 1,869 $155K
J9271 Injection, pembrolizumab, 1 mg 14 13 $135K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,875 1,904 $133K
96375 Therapeutic injection; each additional sequential IV push 3,393 2,177 $125K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,108 3,033 $100K
96417 2,026 1,380 $84K
96367 1,835 1,321 $64K
96415 1,778 1,225 $59K
J1626 Injection, granisetron hydrochloride, 100 mcg 3,295 1,993 $48K
99245 326 326 $33K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 364 197 $23K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 404 404 $22K
J9171 Injection, docetaxel, 1 mg 17 12 $18K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 217 217 $14K
96402 1,067 1,009 $12K
36415 Collection of venous blood by venipuncture 8,992 7,684 $10K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 3,145 2,755 $10K
J2469 Injection, palonosetron hcl, 25 mcg 33 25 $6K
96411 395 277 $6K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 250 107 $5K
99223 Prolong inpt eval add15 m 25 25 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 19 19 $465.51
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 32 32 $458.33
J1100 Injection, dexamethasone sodium phosphate, 1 mg 84 66 $316.84